Blue Owl Capital (NYSE:OWL) Price Target Raised to $28.00 at Oppenheimer

Blue Owl Capital (NYSE:OWL - Get Free Report) had its price target lifted by research analysts at Oppenheimer from $24.00 to $28.00 in a report issued on Thursday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Oppenheimer's price target would suggest a potential upside of 14.15% from the stock's current price.

Other analysts have also recently issued research reports about the stock. JMP Securities restated a "market outperform" rating and set a $27.00 target price on shares of Blue Owl Capital in a report on Wednesday, December 4th. Piper Sandler boosted their price target on Blue Owl Capital from $23.00 to $25.00 and gave the stock an "overweight" rating in a research report on Friday, November 1st. Wells Fargo & Company raised their price objective on Blue Owl Capital from $18.50 to $21.00 and gave the company an "equal weight" rating in a research report on Wednesday, October 9th. Evercore ISI boosted their target price on Blue Owl Capital from $21.00 to $22.00 and gave the stock an "outperform" rating in a report on Tuesday, October 8th. Finally, UBS Group raised their price target on Blue Owl Capital from $20.00 to $27.00 and gave the company a "buy" rating in a report on Tuesday, October 22nd. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat, Blue Owl Capital presently has a consensus rating of "Moderate Buy" and a consensus price target of $22.98.

Blue Owl Capital Trading Down 0.9 %

Shares of NYSE:OWL traded down $0.22 during mid-day trading on Thursday, reaching $24.53. The company had a trading volume of 10,546,985 shares, compared to its average volume of 5,530,866. The firm has a market cap of $36.64 billion, a price-to-earnings ratio of 145.29, a PEG ratio of 1.58 and a beta of 1.14. The company's 50-day moving average price is $22.80 and its 200-day moving average price is $19.60. Blue Owl Capital has a one year low of $13.01 and a one year high of $25.03.

Blue Owl Capital (NYSE:OWL - Get Free Report) last announced its earnings results on Thursday, October 31st. The company reported $0.20 earnings per share for the quarter, meeting analysts' consensus estimates of $0.20. The business had revenue of $600.88 million for the quarter, compared to the consensus estimate of $565.93 million. Blue Owl Capital had a net margin of 4.95% and a return on equity of 19.98%. During the same period last year, the firm posted $0.16 earnings per share. On average, research analysts anticipate that Blue Owl Capital will post 0.78 EPS for the current fiscal year.

Hedge Funds Weigh In On Blue Owl Capital

Institutional investors and hedge funds have recently made changes to their positions in the business. FMR LLC lifted its position in Blue Owl Capital by 29.9% in the third quarter. FMR LLC now owns 35,324,089 shares of the company's stock worth $683,874,000 after buying an additional 8,138,475 shares during the last quarter. Stone Point Capital LLC bought a new stake in shares of Blue Owl Capital in the 2nd quarter worth about $112,749,000. State of New Jersey Common Pension Fund A purchased a new position in shares of Blue Owl Capital during the 2nd quarter worth about $63,115,000. Ceredex Value Advisors LLC bought a new position in Blue Owl Capital during the 2nd quarter valued at about $32,387,000. Finally, Point72 Asset Management L.P. raised its position in Blue Owl Capital by 69.2% in the 2nd quarter. Point72 Asset Management L.P. now owns 4,114,660 shares of the company's stock worth $73,035,000 after purchasing an additional 1,683,408 shares during the period. 35.85% of the stock is owned by hedge funds and other institutional investors.

Blue Owl Capital Company Profile

Blue Owl Capital Inc operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.